May 15, 2023 | Press Releases

Silexon AI Technology, Beijing, appoints Dr Dan Zhu to its advisory board as Chief Advisor of the company on May 15, 2023. Dr. Zhu will closely work with the Founder of the company to provide strategic advisory guidance and leadership (for the company's strategic development, products, financing, and commercialization), including but not limited to leading the management team in formulating the company's development, products, financing, and commercialization related strategies and promoting effective implementation, achieving company milestones, etc.

​

Silexon is an AI technology company driven by the needs for innovation of biotechnology, with a focus on data, empowering life science research to gain a faster, more systematic, and deeper insights into life, health, and diseases, accelerating innovation and commercialization in the field of biotechnology, and addressing the healthcare needs that have yet to be fulfilled. Founded in 2018, Silexon is committed to significantly (up to 90%) improving the efficiency of life science research, reducing costs, and accelerating biotechnology innovation, drug discovery, patent mining, and commercialization using the most advanced artificial intelligence technology.